Piper Jaffray Raises Price Target on Vascular Solutions (VASC) to $49 Following 2Q Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Vascular Solutions Reports Second Quarter Results
July 25, 2016 4:05 PM EDTRevenue increased 10% to $41.2 million, in the top half of guidance rangeAdjusted EPS of $0.33, with corresponding GAAP EPS of $0.31, at the top end of guidanceRaising 2016 revenue guidance to $164 - $166 million, representing an increase of 12% at the midpointRaising 2016 adjusted EPS guidance to $1.22 - $1.26, representing an increase of 12% at the midpoint, with corresponding 2016 GAAP EPS guidance of $0.94 - $0.98
MINNEAPOLIS, July 25, 2016 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq: VASC) today reported financial results for the second quarter ended June 30,... More
